The French public health agency recommends the implementation of a reactive vaccine strategy in post-exposure with the Imvanex vaccine, said to be third generation (in view of its tolerance profile, better than that of the 1st and 2nd generation vaccines and its effectiveness) , ideally administered within 4 days after the at-risk contact and a maximum of 14 days later with a two-dose regimen (or three doses in immunocompromised subjects), 28 days apart, for adult contacts at high risk of smallpox monkeys as defined by Public Health France, including health professionals exposed without individual protection measures.

  • Recommendation
  • Europe
  • France
  • Mpox // Monkeypox